Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P O'Kane

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|February 1, 1995
Tissue angiotensin generation and regulation of vascular toneJ R Cockcroft, K P O'Kane, D J Webb
Journal of Human Hypertension|October 23, 1997
The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive populationG T McInnes, K P O'Kane, J Jonker, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2000
Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal menI B Squire, K P O'Kane, N Anderson, et al.
British Journal of Clinical Pharmacology|October 1, 1994
Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearmK P O'Kane, D J Webb, J G Collier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1996
Association studies, ACE polymorphisms and renal diseaseP N Harden, K P O'Kane, S Ueda, et al.
Journal of Human Hypertension|May 11, 2000
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patientsG T McInnes, K P O'Kane, H Istad, et al.
British Journal of Clinical Pharmacology|November 30, 1999
Blood pressure and renin angiotensin system responses to initiation of treatment with captopril or losartan in heart failureI B Squire, S Robb, G Brennan, et al.
Circulation|May 15, 1996
Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humansW G Haynes, C J Ferro, K P O'Kane, et al.
Journal of the American College of Cardiology|April 13, 2001
Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart diseaseP S Jhund, N Dawson, A P Davie, et al.
QJM : Monthly Journal of the Association of Physicians|November 1, 1994
The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion alleleN Prasad, K P O'Kane, H A Johnstone, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|February 1, 1995
Tissue angiotensin generation and regulation of vascular toneJ R Cockcroft, K P O'Kane, D J Webb
Journal of Human Hypertension|October 23, 1997
The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive populationG T McInnes, K P O'Kane, J Jonker, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2000
Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal menI B Squire, K P O'Kane, N Anderson, et al.
British Journal of Clinical Pharmacology|October 1, 1994
Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearmK P O'Kane, D J Webb, J G Collier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1996
Association studies, ACE polymorphisms and renal diseaseP N Harden, K P O'Kane, S Ueda, et al.
Journal of Human Hypertension|May 11, 2000
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patientsG T McInnes, K P O'Kane, H Istad, et al.
British Journal of Clinical Pharmacology|November 30, 1999
Blood pressure and renin angiotensin system responses to initiation of treatment with captopril or losartan in heart failureI B Squire, S Robb, G Brennan, et al.
Circulation|May 15, 1996
Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humansW G Haynes, C J Ferro, K P O'Kane, et al.
Journal of the American College of Cardiology|April 13, 2001
Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart diseaseP S Jhund, N Dawson, A P Davie, et al.
QJM : Monthly Journal of the Association of Physicians|November 1, 1994
The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion alleleN Prasad, K P O'Kane, H A Johnstone, et al.
Pageof 2